Liposomal amphotericin B
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Poitiers University Hospital
Overview
Liposomal amphotericin B is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Liposomal amphotericin B clinical trials
Explore related
Medical disclaimer. This page summarizes research about Liposomal amphotericin B for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.